These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19720891)

  • 1. Critical points when using vectors.
    Detterbeck FC
    J Clin Oncol; 2009 Oct; 27(30):e166; author reply e167. PubMed ID: 19720891
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited commentary.
    D'Amico T
    Ann Thorac Surg; 2007 Jan; 83(1):221-2. PubMed ID: 17184667
    [No Abstract]   [Full Text] [Related]  

  • 3. Overestimating the influence of the 1999 WHO classification of lung tumors on survival in bronchioloalveloar carcinoma.
    Tsurutani J; Ballas MS; Dennis PA
    J Clin Oncol; 2006 Apr; 24(12):1963; author reply 1963-4. PubMed ID: 16622278
    [No Abstract]   [Full Text] [Related]  

  • 4. Invited commentary.
    Low D
    Ann Thorac Surg; 2004 Nov; 78(5):1753-4. PubMed ID: 15511467
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
    Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
    Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of visceral pleural invasion and tumor size in non-small cell lung cancer.
    Hung JJ; Liu JS; Hsu WH
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):260-1. PubMed ID: 19577109
    [No Abstract]   [Full Text] [Related]  

  • 7. On the use of change in tumor size to predict survival in clinical oncology studies: toward a new paradigm to design and evaluate phase II studies.
    Bruno R; Claret L
    Clin Pharmacol Ther; 2009 Aug; 86(2):136-8. PubMed ID: 19621009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better.
    Sasse AD; Lima JP; Sasse EC; Santos LV
    J Clin Oncol; 2009 Dec; 27(35):e253; author reply e254. PubMed ID: 19884522
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited commentary.
    Yang SC
    Ann Thorac Surg; 2009 Sep; 88(3):928-9. PubMed ID: 19699922
    [No Abstract]   [Full Text] [Related]  

  • 11. Anatomic segmentectomy for stage I non-small-cell lung cancer: comparison of video-assisted thoracic surgery versus open approach.
    Schuchert MJ; Pettiford BL; Pennathur A; Abbas G; Awais O; Close J; Kilic A; Jack R; Landreneau JR; Landreneau JP; Wilson DO; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1318-25.e1. PubMed ID: 19931665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
    Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
    Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
    J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary.
    Sihoe AD
    Ann Thorac Surg; 2009 Aug; 88(2):378-9. PubMed ID: 19632376
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.
    Almasi CE; Høyer-Hansen G; Christensen IJ; Pappot H
    APMIS; 2009 Oct; 117(10):755-61. PubMed ID: 19775344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung-cancer staging with PET-CT.
    Bölükbas S; Baierlein SA; Schirren J
    N Engl J Med; 2009 Oct; 361(16):1606; author reply 1608. PubMed ID: 19842245
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung-cancer staging with PET-CT.
    Sharieff W
    N Engl J Med; 2009 Oct; 361(16):1607; author reply 1608. PubMed ID: 19842248
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimally invasive video-assisted thoracoscopic lobectomy for better clinical outcomes in peripheral T1NO lung cancer.
    Yamashita Y; Mukaida H; Takiyama W; Hirabayashi N; Hisamatsu K; Saeki S; Sato Y; Sakabe R; Tokunaga M; Yoshiyama T; Kobayashi Y; Shimizu S; Hino Y
    Int Surg; 2008; 93(4):226-32. PubMed ID: 19731858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.